For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms ... all treatments were administered as one spray twice daily to preserve blinding.

Due to the risk of rebound congestion (known by some as rhinitis medicamentosa or nasal spray addiction), over-the-counter decongestant medication such as Afrin should not be used for more than three ...

Total symptom scores, nasal obstruction ... favoured loratadine in combination with betamethasone over single-drug therapy (i.e. odds ratio: investigator ratings 0.49, 0.36 and 0.45, and patient ...

After hours: February 4 at 5:14:24 PM EST Loading Chart for DRUG ...

But which is the best bug repellent for you and your family? To narrow the search for the best bug spray money can buy, our experts at CNET have tested over 20 wipes, lotions, sprays and DEET-free ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Side effects of taking these substances include dizziness, accidents, risky behavior, and sometimes suicidal impulses. Long-term use of PCP, ketamine, and MDMA may also lead to withdrawal symptoms ...

Oxide nanoparticles, particularly iron oxide, ceria and silica nanoparticles, hold significant promise for biomedical applications owing to their unique magnetic, catalytic and porous properties ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several elements tailored to different audiences.

Aspartame may also be unsafe for certain people. The Food and Drug Administration (FDA) first approved aspartame for use as a sweetener in 1974. The FDA has reviewed over 100 studies about the ...